RE:AGMLake O,
Thanks for sharing with us, I am happy you attended. Would have joined you if I was around, but since I live in Northern Europe, this is not really an option.
Regular QA-sessions would be a good thing, but if the company was more transparent as to deal details and also as to what is going on in the company, that would certainly be preferred.
It would be good to understand the strategy going forward, what actions have been implemented and what actions are planned for, including a timetable.
The company communicated a number of statements in the June 15 News Release, and it would be a good thing if they also followed through on these statements. Alternatively, the trustworthiness of management will be weakened further.
Items to be answered could, for instance, be:
1 What steps for sustainable and rapid growth of the company have been initiated? And what steps are planned, including timetable.
2 What is the status of the strategic review of every facet of the company that the Board has begun? When is the review to be finalized and the conclusion communicated?
3 What is the status of organizational changes and management expansion?
4 Updates have not been communicated throughout the remainder of 2022 as stated. Will there be a change in communication policy in order to comply with company public statements?
5 What is the status of ramp-up and acceleration of pipeline development?
6 Sirona has stated that they will seek institutional analysis and investment. How is this going to be executed? It is not possible without a transparent approach where these parties are given figures. If institutional investors are given figures but not retail investors, this must be reported to the authorities. All stakeholders must be given the same amount of information at the same time.
7 Is Wolfgang still around? What has he been up to since arriving and what is the plan for him going forward?
The consequence of the present non-disclosure policy is that today only management knows if the deal with Abbvie was a successful one and only management knows if Sirona is a good buy or a good sell at the current stock price. The consequence of being non-transparent is also that the stock price deteriorates since it is impossible for new investors to do a due diligence of the company. This is since no numbers are provided. New investors, including professional institutional investors, will see this instantly.
Wish all long-time investors a happy new 2023. Last year was a terrible one in Northern Europe.